Laboratories
Laboratories are composed of investigators studying the molecular origin
and growth mechanisms of cancer and AIDS. Experts in fields such as molecular
and cell biology, developmental biology, biochemistry, carcinogenesis,
and immunology are providing the knowledge base required to understand
and treat these and, potentially, other diseases as well. NOTE: “Laboratory
of” has been listed at the end of each title that begins with this designation
for ease of use.
Cancer
and Developmental Biology Laboratory – Alan O. Perantoni, Ph.D., (Acting)
Cancer Prevention, Laboratory of - Nancy Colburn, Ph.D. (also at NCI-Bethesda)
Cell and Developmental Signaling, Laboratory of - Deborah K. Morrison, Ph.D.
Comparative
Carcinogenesis, Laboratory of – Larry Keefer, Ph.D.
Experimental
Immunology, Laboratory of – Giorgio Trinchieri, M.D.
Gene
Regulation and Chromosome Biology Laboratory – Jeffrey Strathern,
Ph.D.
Genomic
Diversity, Laboratory of – Stephen O’Brien, Ph.D.
Macromolecular Crystallography
Laboratory – Alexander Wlodawer, Ph.D.
Medicinal
Chemistry, Laboratory of – Victor Marquez, Ph.D.
Metabolism, Laboratory of - Frank Gonzalez, Ph.D. (also at NCI-Bethesda)
Molecular
Immunoregulation, Laboratory of – Joost Oppenheim, M.D.
Nanotechnology Characterization Lab – Scott E. McNeil, Ph.D.
Protein Dynamics and Signaling, Laboratory of - Allan Weissman, M.D.
Retroviral
Replication Laboratory – Stephen Hughes, Ph.D.
Structural
Biophysics Laboratory – R. Andrew Byrd, Ph.D.
Branches
Biological Resources Branch -Stephen P. Creekmore,
Ph.D., M.D.
Biological
Testing Branch - Melinda Hollingshead D.V.M., Ph.D.
HIV DRP Host-Virus Interaction Branch - Stephen H. Hughes, Ph.D.
Natural
Products Branch - David Newman, Ph.D.
Screening
Technologies Branch -Robert H. Shoemaker, Ph.D.
Vaccine Branch - Jay Berzofsky, M.D., Ph.D. (also at NCI-Bethesda)
Programs
Programs encompass investigators, organized within a specific field of
research, who are working together to solve a complex scientific problem.
AIDS
Vaccine Program – Jeffrey D. Lifson, M.D.
Advanced Technology Program (ATP) - Tim Harris, Ph.D
Biopharmaceuticals
Development Program - George Mitra, Ph.D.
Cancer Inflammation Program - Giorgio Trinchieri, M.D.
CCR Nanobiology Program - Robert Blumenthal, Ph.D.
Clinical
Monitoring Research Program (CMRP) - Beth Baseler, M.S.
Clinical
Services Program - Michael W. Baseler, Ph.D.
Developmental Therapeutics
Program - Jerry M. Collins, Ph.D., Associate Director
HIV
Drug Resistance Program – Stephen H. Hughes, Ph.D.
Laboratory Animal Sciences Program - Hendrick
Bedigian, Ph.D.
Molecular Targets Development
Program - James B. McMahon, Ph.D.
Mouse
Cancer Genetics Program – Terry Van Dyke, Ph.D.
|